HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Share Price Falls 9.73% Today

Himalaya Nutravedics India Share Price fell 9.73% to Rs 135.05, with market capitalisation at Rs 131.74 crore as of 19 October 2026 at 10:23:09 AM IST. The move puts Himalaya Nutravedics India Share Price in focus for investors tracking healthcare stocks, especially because the day’s decline was measured against a previous close of Rs 149.6. The price move is confirmed in Univest data; a company-specific reason has not been established. The latest Univest figures therefore point to a sharp share price fall without a stated trigger, making the stock important for anyone scanning Himalaya Nutravedics India Share Price news, price action and fundamental analysis today.

The headline numbers matter because the stock opened at Rs 147, touched Rs 147 and then moved as low as Rs 132.05 during the ongoing session. That range places Himalaya Nutravedics India Share Price below the previous close and near the lower end of the day’s band. For a Micro Cap company, such a move can quickly change how the market reads Himalaya Nutravedics India Share Price today. Univest is tracking the stock through the day, and the current data makes this a notable stock news event rather than a routine fluctuation.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 135.05
Previous Close	Rs 149.6
Today's Move	-Rs 14.55 (-9.73%)
Open	Rs 147
High	Rs 147
Low	Rs 132.05
Market Capitalisation	Rs 131.74 crore
Market Cap Category	Micro Cap

Himalaya Nutravedics India Share Price today shows a clear intraday decline from Rs 149.6 to Rs 135.05, a fall of Rs 14.55 or 9.73%. The stock opened at Rs 147, matched that level as the day’s high, and touched a low of Rs 132.05. That sequence shows that the share price was under pressure after the open and stayed within a relatively narrow band, with the low sitting much closer to the current price than the high. The company’s market capitalisation of Rs 131.74 crore places it in the Micro Cap category, which is the same context Univest uses throughout this article. For readers following Himalaya Nutravedics India Share Price live, the key takeaway is the size of the fall and the fact that the move happened in the current session itself. The next question is whether the fundamentals offer more context for this decline, which is where Himalaya Nutravedics India Share Price analysis becomes useful.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 131.74 crore
P/E Ratio	17.83x
P/B Ratio	3.07x
EPS	Rs 8.39
Book Value Per Share	Rs 48.69
Dividend Yield	0%

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) fundamental metrics show P/E 17.83x, P/B 3.07x. These ratios show where the company stands today and are not a call to buy or sell.

HIMALAYA NUTRAVEDICS INDIA LIM has a market capitalisation of Rs 131.74 crore and falls in the Micro Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 17.83x, P/B at 3.07x should be read against the sector and peer benchmarks rather than as a standalone signal. According to latest Univest data, additional metrics include EPS of Rs 8.39, book value per share of Rs 48.69, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.95x, median ROE of 10.96%, median ROCE of 13.01%. Together they describe the fundamental backdrop without implying a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	17.83x
Benchmark Median P/E	30.95x
Benchmark Average P/E	46.82x
Benchmark P/E Range	3.1x to 629.67x
Company P/B Ratio	3.07x
Benchmark Median P/B	2.82x
Benchmark Average P/B	4.18x
Benchmark Median ROE	10.96%
Benchmark Average ROE	9.51%
Benchmark Median ROCE	13.01%
Benchmark Average ROCE	12.48%
Company Market Capitalisation	Rs 131.74 crore
Benchmark Median Market Cap	Rs 720.23 crore
Benchmark Average Market Cap	Rs 13,282.41 crore

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 17.83x, which is below the benchmark median of 30.95x, a difference of -42.39%. A P/E difference of this kind is a reference point rather than a recommendation.

Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Sun Pharmaceutical Industries	SUNPHARMA	4,22,282.95	34.91	4.88	14.85	19.11
Divi's Laboratories	DIVISLAB	2,44,762.03	83.68	13.86	16.19	21.51
Torrent Pharmaceuticals	TORNTPHARM	1,73,447.74	79.53	19.32	26.76	19.27
Zydus Lifesciences	ZYDUSLIFE	1,12,149.36	24.85	4.16	19.69	21.39
Laurus Labs	LAURUSLABS	1,11,250.29	101.75	19.73	18.31	18.2

HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a P/E ratio of 17.83x compared with the displayed peer median of 79.53x. This is a relative valuation comparison, not a buy or sell signal. HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) has a market capitalisation of Rs 131.74 crore. All 5 peers shown have a larger market capitalisation.

Why Investors Are Watching Himalaya Nutravedics India

• Himalaya Nutravedics India Share Price is down 9.73% in the current session, with the move taking the stock from Rs 149.6 to Rs 135.05.
• The price action is clear: the stock opened at Rs 147, touched Rs 147, and traded down to Rs 132.05 during the same session.
• Himalaya Nutravedics India Share Price sits in the Micro Cap category with a market capitalisation of Rs 131.74 crore.
• The P/E ratio of 17.83 is below the same-industry benchmark median of 30.95 and below the benchmark average of 46.82.
• The P/B ratio of 3.07 is near the sector median of 2.82, while EPS of Rs 8.39 and book value of Rs 48.69 add basic earnings context.

About Himalaya Nutravedics India Lim

Himalaya Nutravedics India Lim operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The company is tracked by Univest as a Micro Cap stock with market capitalisation of Rs 131.74 crore. The available financial context shows earnings per share of Rs 8.39, book value of Rs 48.69 and a dividend yield of 0. These figures help frame Himalaya Nutravedics India Share Price in terms of valuation and scale. For investors following Himalaya Nutravedics India Stock News, the most relevant business context today is the company’s placement within a broad pharmaceutical industry that includes much larger listed peers. That scale difference is important when reading any move in the share price.

Track Himalaya Nutravedics India Share Price on Univest

Use HIMALAYA NUTRAVEDICS INDIA LIM (HNIL) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.

Readers can track Himalaya Nutravedics India Share Price on Univest for live price moves, fundamental ratios, 52-week levels and market insights in one place. Univest also presents stock news, share price updates and sector context so the day’s move can be read alongside valuation and peer data. For Himalaya Nutravedics India Share Price today, that combination is useful because the price fall is already confirmed and the broader context remains important.

Frequently Asked Questions

Why is Himalaya Nutravedics India Share Price falling today?

Ans. Himalaya Nutravedics India Share Price is down 9.73% to Rs 135.05. The price move is confirmed in Univest data; a company-specific reason has not been established. The move stands out because it followed a previous close of Rs 149.6.

What is the current Himalaya Nutravedics India Share Price?

Ans. Himalaya Nutravedics India Share Price is Rs 135.05 as of 19 October 2026 at 10:23:09 AM IST. The stock is trading below its previous close of Rs 149.6 after an intraday decline of Rs 14.55.

How much did Himalaya Nutravedics India Share Price decline today?

Ans. Himalaya Nutravedics India Share Price declined by Rs 14.55, or 9.73%, in the ongoing session. The stock opened at Rs 147, touched Rs 147, and hit a low of Rs 132.05 during the same session.

What is Himalaya Nutravedics India market capitalisation?

Ans. Himalaya Nutravedics India has a market capitalisation of Rs 131.74 crore. Univest classifies the company as a Micro Cap stock, which provides scale context when reading the share price fall and valuation metrics.

What does Himalaya Nutravedics India Share Price valuation show?

Ans. Himalaya Nutravedics India Share Price sits at a P/E of 17.83 and a P/B of 3.07. The P/E is below the same-industry median of 30.95, while the P/B is close to the benchmark median of 2.82.

What are the key financial metrics behind Himalaya Nutravedics India Share Price?

Ans. The key financial metrics are EPS of Rs 8.39, book value of Rs 48.69 and dividend yield of 0. These figures help explain the valuation backdrop for Himalaya Nutravedics India Share Price without adding any unverified catalyst.

How does Himalaya Nutravedics India compare with healthcare peers?

Ans. Himalaya Nutravedics India Share Price is lower on scale and has a much smaller market cap than peers such as Sun Pharma, Divi’s Laboratories and Torrent Pharmaceuticals. Its P/E is also below several listed peers in the same industry.

Is Himalaya Nutravedics India Share Price linked to sector weakness today?

Ans. The available numbers show a fall in Himalaya Nutravedics India Share Price, but they do not establish a sector-wide trigger. The stock is best read against the Healthcare and Pharmaceuticals & Drugs benchmark set, where valuation remains mixed.

Should investors track Himalaya Nutravedics India Share Price on Univest?

Ans. Yes, investors tracking Himalaya Nutravedics India Share Price can follow live updates, valuation ratios, 52-week levels and sector context on Univest. That helps place today’s decline alongside the company’s earnings and book-value metrics.